
|Podcasts|May 22, 2023
Untold Tales Behind Therapeutic Antibody Production and Screening with Twist Bioscience
Author(s)Twist
Creating a new therapeutic drug can take a decade or more to get to patients. Antibody production and discovery play an integral role in setting the stage for success at later stages of development. If a high affinity, functional antibody candidate is discovered early, the timeline to a finished targeted and effective therapeutic drug may be significantly reduced. In this podcast we will go through the untold tales of antibody production and discovery, as well as how Twist has optimized a process for antibody production and screening for potential therapeutics.
To learn more about Twist Bioscience's antibody production and characterization services, visit twistbioscience.com/antibodyproduction
For research use only. Not for Diagnostic procedures.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
WHO Finalizes United States’ Withdrawal from Organization: Report
4
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
5




